Drug Search Results
More Filters [+]

KAT-101

Alternative Names: KAT-101, KAT 101, KAT101
Latest Update: 2023-11-13
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Primocure Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for KAT-101

Countries in Clinic: Korea

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Hepatocellular Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NLP-KAT-101

P2

Active, not recruiting

Hepatocellular Carcinoma

2025-11-01

Recent News Events

Date

Type

Title